![Dale L. Ludwig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Dale L.
Ludwig worked as the Chief Scientific Officer & Vice President at ImClone LLC and as the Head of Molecular & Cellular Engineering at ImClone Systems Corp.
He also worked as the Chief Scientific & Technology Officer at Actinium Pharmaceuticals, Inc. from 2018 to 2021.
Ludwig holds a doctorate degree from East Carolina University and an undergraduate degree from James Madison University.
Anciens postes connus de Dale L. Ludwig
Sociétés | Poste | Fin |
---|---|---|
ACTINIUM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 26/07/2021 |
ImClone Systems Corp. | Corporate Officer/Principal | - |
ImClone LLC
![]() ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Directeur Technique/Scientifique/R&D | - |
Formation de Dale L. Ludwig
James Madison University | Undergraduate Degree |
East Carolina University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
ImClone LLC
![]() ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
ImClone Systems Corp. | Health Technology |